A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

NCT06068465 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease Psychosis

Interventions

DRUG: pimavanserin tartrate
DRUG: placebo

Sponsor

Tasly Pharmaceutical Group Co., Ltd